Literature DB >> 15778049

Accelerated aging: prediction of chemical stability of pharmaceuticals.

Kenneth C Waterman1, Roger C Adami.   

Abstract

Methods of rapidly and accurately assessing the chemical stability of pharmaceutical dosage forms are reviewed with respect to the major degradation mechanisms generally observed in pharmaceutical development. Methods are discussed, with the appropriate caveats, for accelerated aging of liquid and solid dosage forms, including small and large molecule active pharmaceutical ingredients. In particular, this review covers general thermal methods, as well as accelerated aging methods appropriate to oxidation, hydrolysis, reaction with reactive excipient impurities, photolysis and protein denaturation.

Mesh:

Substances:

Year:  2005        PMID: 15778049     DOI: 10.1016/j.ijpharm.2004.12.013

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  33 in total

1.  Quantitative analysis of therapeutic drugs in dried blood spot samples by paper spray mass spectrometry: an avenue to therapeutic drug monitoring.

Authors:  Nicholas Edward Manicke; Paul Abu-Rabie; Neil Spooner; Zheng Ouyang; R Graham Cooks
Journal:  J Am Soc Mass Spectrom       Date:  2011-06-21       Impact factor: 3.109

Review 2.  Impact of excipient interactions on solid dosage form stability.

Authors:  Ajit S Narang; Divyakant Desai; Sherif Badawy
Journal:  Pharm Res       Date:  2012-06-16       Impact factor: 4.200

3.  Stabilization of vaccines and antibiotics in silk and eliminating the cold chain.

Authors:  Jeney Zhang; Eleanor Pritchard; Xiao Hu; Thomas Valentin; Bruce Panilaitis; Fiorenzo G Omenetto; David L Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

4.  Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms.

Authors:  Kenneth C Waterman; Anthony J Carella; Michael J Gumkowski; Patrick Lukulay; Bruce C MacDonald; Michael C Roy; Sheri L Shamblin
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

5.  Pharmaceutical quality by design: product and process development, understanding, and control.

Authors:  Lawrence X Yu
Journal:  Pharm Res       Date:  2008-01-10       Impact factor: 4.200

6.  The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability.

Authors:  Kenneth Craig Waterman
Journal:  AAPS PharmSciTech       Date:  2011-07-12       Impact factor: 3.246

7.  Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration.

Authors:  Sorina Morar-Mitrica; Manasi Puri; Alexandra Beumer Sassi; Joshua Fuller; Ping Hu; George Crotts; Douglas Nesta
Journal:  MAbs       Date:  2015       Impact factor: 5.857

8.  Evaluation of degradation kinetics and physicochemical stability of tenofovir.

Authors:  Vivek Agrahari; Sandeep Putty; Christiane Mathes; James B Murowchick; Bi-Botti C Youan
Journal:  Drug Test Anal       Date:  2014-05-12       Impact factor: 3.345

Review 9.  Non-Arrhenius protein aggregation.

Authors:  Wei Wang; Christopher J Roberts
Journal:  AAPS J       Date:  2013-04-25       Impact factor: 4.009

10.  Lactose contaminant as steroid degradation enhancer.

Authors:  Florentine Nieuwmeyer; Kees van der Voort Maarschalk; Herman Vromans
Journal:  Pharm Res       Date:  2008-08-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.